Revolution Medicines (RVMD) Interest & Investment Income (2019 - 2026)
Revolution Medicines' quarterly Interest & Investment Income came in at $19.5 million in Q1 2026, down 21.7% year-on-year from $24.9 million in Q1 2025, and down 8.38% quarter-over-quarter from $21.3 million in Q4 2025.
Revolution Medicines has reported Interest & Investment Income for 8 years, with the latest figure at $19.5 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 21.7% year-over-year to $19.5 million; the trailing twelve-month figure through Mar 2026 stood at $62.0 million (down 29.59% YoY), and the FY2025 full-year result was $90.7 million, up 4.39% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $19.5 million, down from $21.3 million in the prior quarter.
- The five-year high for Interest & Investment Income was $24.9 million in Q1 2025, with the low at -$899000.0 in Q2 2025.
- Average Interest & Investment Income over 5 years is $13.6 million, with a median of $19.0 million recorded in 2023.
- Year-over-year, Interest & Investment Income jumped 2237.42% in 2023 and sank 104.18% in 2025.
- Tracing RVMD's Interest & Investment Income over 5 years: stood at $5.1 million in 2022, then soared by 273.78% to $19.0 million in 2023, then increased by 11.85% to $21.2 million in 2024, then advanced by 0.32% to $21.3 million in 2025, then decreased by 8.38% to $19.5 million in 2026.
- The last three Interest & Investment Income figures came in at $19.5 million (Q1 2026), $21.3 million (Q4 2025), and $22.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - | 19.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.51 Mn |
| Dec 31, 2025 | 21.29 Mn |
| Sep 30, 2025 | 22.08 Mn |
| Jun 30, 2025 | -899,000.00 |
| Mar 31, 2025 | 24.92 Mn |
| Dec 31, 2024 | 21.23 Mn |
| Sep 30, 2024 | 20.41 Mn |
| Jun 30, 2024 | 21.49 Mn |
| Mar 31, 2024 | 23.76 Mn |
| Dec 31, 2023 | 18.98 Mn |
| Sep 30, 2023 | 10.95 Mn |
| Jun 30, 2023 | 10.50 Mn |
| Mar 31, 2023 | 7.06 Mn |
| Dec 31, 2022 | 5.08 Mn |
| Sep 30, 2022 | 2.91 Mn |
| Jun 30, 2022 | 867,000.00 |
| Mar 31, 2022 | 302,000.00 |
| Dec 31, 2021 | 237,000.00 |
| Sep 30, 2021 | 223,000.00 |
| Jun 30, 2021 | 236,000.00 |
| Mar 31, 2021 | 233,000.00 |
| Dec 31, 2020 | 252,000.00 |
| Sep 30, 2020 | 347,000.00 |
| Jun 30, 2020 | 730,000.00 |
| Mar 31, 2020 | 909,000.00 |
| Dec 31, 2019 | 618,000.00 |
| Sep 30, 2019 | 766,000.00 |
| Jun 30, 2019 | 470,000.00 |
| Mar 31, 2019 | 335,000.00 |